Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms.
Inamo J, Suzuki A, Ueda MT, Yamaguchi K, Nishida H, Suzuki K, Kaneko Y, Takeuchi T, Hatano H, Ishigaki K, Ishihama Y, Yamamoto K, Kochi Y. Inamo J, et al. Among authors: takeuchi t. Nat Commun. 2024 May 28;15(1):4285. doi: 10.1038/s41467-024-48615-4. Nat Commun. 2024. PMID: 38806455 Free PMC article.
[Mediastinal teratoma].
Yamamoto K, Takeuchi T. Yamamoto K, et al. Among authors: takeuchi t. Ryoikibetsu Shokogun Shirizu. 1994;(4):363-5. Ryoikibetsu Shokogun Shirizu. 1994. PMID: 8007183 Review. Japanese. No abstract available.
Conservative sequences in 3'UTR of TCRzeta mRNA regulate TCRzeta in SLE T cells.
Tsuzaka K, Itami Y, Kumazawa C, Suzuki M, Setoyama Y, Yoshimoto K, Suzuki K, Abe T, Takeuchi T. Tsuzaka K, et al. Among authors: takeuchi t. Biochem Biophys Res Commun. 2008 Mar 7;367(2):311-7. doi: 10.1016/j.bbrc.2007.12.145. Epub 2008 Jan 3. Biochem Biophys Res Commun. 2008. PMID: 18177736
A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
Hashimoto J, Garnero P, van der Heijde D, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Yoshikawa H, Nishimoto N. Hashimoto J, et al. Among authors: takeuchi t. Mod Rheumatol. 2009;19(3):273-82. doi: 10.1007/s10165-009-0170-4. Epub 2009 May 19. Mod Rheumatol. 2009. PMID: 19452245 Clinical Trial.
Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells.
Tanino M, Matoba R, Nakamura S, Kameda H, Amano K, Okayama T, Nagasawa H, Suzuki K, Matsubara K, Takeuchi T. Tanino M, et al. Among authors: takeuchi t. Biochem Biophys Res Commun. 2009 Sep 18;387(2):261-5. doi: 10.1016/j.bbrc.2009.06.149. Epub 2009 Jul 3. Biochem Biophys Res Commun. 2009. PMID: 19577537
Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study.
Hashimoto J, Garnero P, van der Heijde D, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Yoshikawa H, Nishimoto N. Hashimoto J, et al. Among authors: takeuchi t. Mod Rheumatol. 2011 Feb;21(1):10-5. doi: 10.1007/s10165-010-0325-3. Epub 2010 Jun 24. Mod Rheumatol. 2011. PMID: 20574648 Free PMC article. Clinical Trial.
5,731 results